Showing results (31-40 of 37) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
The Journal of Pharmacology and Experimental Therapeutics|May 15, 1998
Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylationK E Lipson, L Pang, L J Huber, et al.Circulation Research|April 3, 2001
Weekly dosing with the platelet-derived growth factor receptor tyrosine kinase inhibitor SU9518 significantly inhibits arterial stenosisY Yamasaki, K Miyoshi, N Oda, et al.Cancer Research|August 17, 2001
A novel cdk2-selective inhibitor, SU9516, induces apoptosis in colon carcinoma cellsM E Lane, B Yu, A Rice, et al.The Journal of Pharmacology and Experimental Therapeutics|January 1, 1996
The unusual binding properties of the endothelin receptor antagonist CGS 27830 distinguishes receptor/agonist interactionsM H Chin, C L Cioffi, M Garay, et al.Proceedings of the National Academy of Sciences of the United States of America|September 6, 2001
Suppression of Ras-mediated tumorigenicity and metastasis through inhibition of the Met receptor tyrosine kinaseK A Furge, D Kiewlich, P Le, et al.Respiratory Research|November 8, 2018
Quantitative CT analysis using functional imaging is superior in describing disease progression in idiopathic pulmonary fibrosis compared to forced vital capacityJ Clukers, M Lanclus, B Mignot, et al.Journal of Medicinal Chemistry|January 15, 1999
Carboxy-substituted cinnamides: a novel series of potent, orally active LTB4 receptor antagonistsP D Greenspan, R A Fujimoto, P J Marshall, et al.Pageof 4